Taxotere - Fighting Cancer

Experimental drug modestly boosts survival in men with advanced prostate cancer, study findsFor the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options ...

Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy. The Food and Drug Administration on Monday posted its review of the drug for a new use against ...

Dendreon (DNDN) appears to have defied the many skeptics of its controversial experimental prostate cancer vaccine, Provenge. The drug extended survival in patients in the last stages of the disease by a median of 4.1 months, according to a the results of ...

Topic: Taxotere

Sanofi drug shows promise against prostate cancer

FDA says OSI drug effective against lung cancer

Dendreon's Prostate Vaccine Validated with Drama

From Around the Web

Video Gallery

Follow this Topic with...